Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:40 PM
Ignite Modification Date:
2025-12-24 @ 4:40 PM
NCT ID:
NCT00179166
Eligibility Criteria:
Inclusion Criteria:
* Adults ≥ 18 years of age admitted to the intensive care unit
* New onset acute renal failure (ARF) or ARF superimposed on chronic kidney disease
* ARF will be defined by a sustained (over 24 hours) increase in serum creatinine \> 0.5 mg/dl from baseline
* Patients will be recruited for the study within 3-5 days following establishment of ARF
Exclusion Criteria:
* Institutionalized patient
* Previous kidney transplant
* Pregnancy
* Unable to obtain consent from subject or legally recognized representative
* ARF from urinary tract obstruction or a volume responsive pre-renal state.
* Liver Failure
* Recent cerebrovascular accident (CVA)
* Coagulopathy defined as: Platelets \< 50, PT \> 20, INR \> 2.0 if the patient requires the placement of an arterial or venous catheter; if the patient does not require the placement of an arterial or venous catheter for the study, coagulopathy will not be a basis for exclusion.
* Life expectancy \< 48 hours
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00179166
Study Brief:
Protocol Section:
NCT00179166